X-FAB Q3 2024 Financial Performance

In the third quarter of 2024, X-FAB Silicon Wafers (ticker: X-FAB) reported a 12% year-on-year revenue decline to $206 million, in line with the company’s guidance. Despite this dip, revenues increased 1% compared to the previous quarter.

CEO Rudi De Winter discussed the financial performance, noting growth in the automotive sector, primarily in China, along with expectations for long-term growth due to demand in the automotive and medical semiconductor markets. Contrarily, the industrial and medical sectors faced declines, and the silicon carbide segment saw a significant drop. The company remains optimistic about future growth despite market uncertainties.

Key Takeaways

• Q3 revenue: $206 million, down 12% year-on-year but up 1% quarter-on-quarter.
• Growth in the automotive sector, especially in China, contrasted with declines in industrial and medical sectors.
• Bookings increased year-on-year, achieving a book-to-bill ratio of 1.05.
• Backlog decreased due to long-term orders not counted in the total.
• Q4 revenue forecast: $195 million to $205 million, with an EBITDA margin of 22% to 25%.
• Full-year revenue guidance adjusted down, but optimistic long-term growth remains.

Company Outlook

• Long-term growth expected in semiconductor demand, especially in automotive and medical markets.
• Q4 2024 revenue projection between $195 million and $205 million.
• Revised full-year revenue guidance: $822 million to $832 million.
• Full-year EBITDA margin forecast between 23.4% and 24%.

Bearish Highlights

• Revenue declined 12% year-on-year.
• Significant declines in industrial and medical sectors (41% and 29% respectively).
• Silicon carbide sales dropped by 60% year-on-year.
• Micro systems business down 11% due to market weaknesses.

Bullish Highlights

• The automotive segment grew by 8% year-on-year, with 55% increase in China.
• Bookings rose 4% year-on-year.
• Prototype revenues increased 12% quarter-on-quarter.

Misses

• Production slowdown in Malaysia impacted revenue by $15 million to $20 million.
• Significant declines in silicon carbide sales and micro systems business.

Q&A Highlights

• Rudi detailed risk controls for chemical use in fabs.
• Price negotiations for 2025 indicate moderate price evolution.
• Strong demand for 180nm and 110nm production justifies ongoing CapEx investments.
• Repayments of prepayments to begin in 2024, with significant amounts expected by year-end.
• CapEx plans for 2025 are about $150 million in Q1, tapering to about $50 million per quarter thereafter.

X-FAB's performance reflects challenges in the semiconductor industry, yet the leadership maintains a positive view on future prospects. The growth in China’s automotive sector and strategic investments position X-FAB for potential long-term success. The next earnings update will be on February 6.

InvestingPro Insights

X-FAB's financial performance aligns with key metrics from InvestingPro. Despite the 12% year-on-year revenue decline in Q3 2024, the company may have future expansion potential driven by optimism in the automotive and medical semiconductor markets. Notably, X-FAB trades at a low P/E ratio, indicating possible undervaluation for investors.

Conclusion

X-FAB’s Q3 performance highlights both challenges and opportunities. With essential growth in certain sectors and strategic investments, the company remains poised to navigate current market conditions and capitalize on future demand.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.